Silgan Q3 Adjusted EPS Hits Record $1.31, Full-Year Guidance Midpoint Raised

Silgan (SLGN) reported Q3 adjusted EPS of $1.31, up 7% YoY, and raised 2026 guidance. Sales rose 2% to $2B, with adjusted EBIT up 6% to $235M. Growth was driven by fragrance, pharma, and metal cans, offsetting inflation and weak consumer demand. Management expects continued EPS growth and free cash flow in 2027, despite mixed volume trends.

Silgan (SLGN) raised its full-year 2026 adjusted EPS outlook to $3.83-$3.93, up from $3.72 in 2025. Q4 adjusted EPS is projected at $0.76-$0.86. The company expects $450M in free cash flow for 2026. Silgan also discussed its planned acquisition of Trivium, expected to close in mid-2027, which will create two new packaging businesses.

Silgan Holdings (SLGN) reported Q3 2026 earnings with record adjusted EPS and raised guidance. Weak consumer demand impacted volumes, especially in food, beverage, and home care. Margins in dispensing and specialty closures declined for six quarters but are expected to stabilize in Q4. The Trivium acquisition will require investments and may pose execution risks. CEO Adam Greenlee highlighted growth in wet pet food, fragrance, and prescription pharma.

Silgan reported a Q3 2026 net income decline to $105m ($0.99 per share) from $113.3m ($1.06 per share) year-over-year, despite a 2% sales increase to $2.04bn. EBIT fell to $191.7m. The company raised its 2026 adjusted earnings outlook to $3.83-$3.93 per share and announced a $3.4bn acquisition of Trivium Packaging.

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Silgan Holdings Inc. Exhibit 99.1 SILGAN ANNOUNCES THIRD QUARTER 2026 RESULTS; RAISES FULL YEAR EARNINGS ESTIMATE MIDPOINT H ighlights • Announced transformative portfolio acceleration through the acquisition of Trivium • Achieved double digit growth in dispensing products for ph

Silgan (SLGN) reported Q3 2026 earnings, with record adjusted EPS at the high end of estimates. Despite cost headwinds, the company saw growth in key segments, including Dispensing and Specialty Closures, and Metal Containers. Silgan expects to meet increased financial expectations for the year and anticipates the acquisition of Trivium to close mid-2027. Net sales were $2 billion, up 2% YoY, with adjusted EBIT of $235 million, up 6% YoY, and adjusted EPS of $1.31, up 7% YoY.